Citrulline stimulates muscle protein synthesis, by reallocating ATP consumption to muscle protein synthesis.


Journal

Journal of cachexia, sarcopenia and muscle
ISSN: 2190-6009
Titre abrégé: J Cachexia Sarcopenia Muscle
Pays: Germany
ID NLM: 101552883

Informations de publication

Date de publication:
08 2019
Historique:
received: 26 10 2018
accepted: 21 03 2019
pubmed: 10 5 2019
medline: 21 7 2020
entrez: 10 5 2019
Statut: ppublish

Résumé

Animal studies and clinical data support the interest of citrulline as a promising therapeutic for sarcopenia. Citrulline is known to stimulate muscle protein synthesis, but how it affects energy metabolism to support the highly energy-dependent protein synthesis machinery is poorly understood. Here, we used myotubes derived from primary culture of mouse myoblasts to study the effect of citrulline on both energy metabolism and protein synthesis under different limiting conditions. When serum/amino acid deficiency or energy stress (mild uncoupling) were applied, citrulline stimulated muscle protein synthesis by +22% and +11%, respectively. Importantly, this increase was not associated with enhanced energy status (ATP/ADP ratio) or mitochondrial respiration. We further analysed the share of mitochondrial respiration and thus of generated ATP allocated to different metabolic pathways by using specific inhibitors. Our results indicate that addition of citrulline allocated an increased share of mitochondrially generated ATP to the protein synthesis machinery under conditions of both serum/amino acid deficiency (+28%) and energy stress (+21%). This reallocation was not because of reduced ATP supply to DNA synthesis or activities of sodium and calcium cycling ion pumps. Under certain stress conditions, citrulline increases muscle protein synthesis by specifically reallocating mitochondrial fuel to the protein synthesis machinery. Because ATP/ADP ratios and thus Gibbs free energy of ATP hydrolysis remained globally constant, this reallocation may be linked to decreased activation energies of one or several ATP (and GTP)-consuming reactions involved in muscle protein synthesis.

Sections du résumé

BACKGROUND
Animal studies and clinical data support the interest of citrulline as a promising therapeutic for sarcopenia. Citrulline is known to stimulate muscle protein synthesis, but how it affects energy metabolism to support the highly energy-dependent protein synthesis machinery is poorly understood.
METHODS
Here, we used myotubes derived from primary culture of mouse myoblasts to study the effect of citrulline on both energy metabolism and protein synthesis under different limiting conditions.
RESULTS
When serum/amino acid deficiency or energy stress (mild uncoupling) were applied, citrulline stimulated muscle protein synthesis by +22% and +11%, respectively. Importantly, this increase was not associated with enhanced energy status (ATP/ADP ratio) or mitochondrial respiration. We further analysed the share of mitochondrial respiration and thus of generated ATP allocated to different metabolic pathways by using specific inhibitors. Our results indicate that addition of citrulline allocated an increased share of mitochondrially generated ATP to the protein synthesis machinery under conditions of both serum/amino acid deficiency (+28%) and energy stress (+21%). This reallocation was not because of reduced ATP supply to DNA synthesis or activities of sodium and calcium cycling ion pumps.
CONCLUSIONS
Under certain stress conditions, citrulline increases muscle protein synthesis by specifically reallocating mitochondrial fuel to the protein synthesis machinery. Because ATP/ADP ratios and thus Gibbs free energy of ATP hydrolysis remained globally constant, this reallocation may be linked to decreased activation energies of one or several ATP (and GTP)-consuming reactions involved in muscle protein synthesis.

Identifiants

pubmed: 31070021
doi: 10.1002/jcsm.12435
pmc: PMC6711414
doi:

Substances chimiques

Muscle Proteins 0
Citrulline 29VT07BGDA
Adenosine Triphosphate 8L70Q75FXE

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

919-928

Informations de copyright

© 2019 The Authors. Journal of Cachexia, Sarcopenia and Muscle published by John Wiley & Sons Ltd on behalf of the Society on Sarcopenia, Cachexia and Wasting Disorders.

Références

Nutr Rev. 2007 Mar;65(3):122-9
pubmed: 17425063
Nature. 2016 Aug 11;536(7615):229-33
pubmed: 27487210
Dig Dis Sci. 2007 Aug;52(8):1826-32
pubmed: 17406837
ACS Synth Biol. 2018 Jan 19;7(1):218-226
pubmed: 28915016
Kidney Int. 1995 Jun;47(6):1522-7
pubmed: 7643520
Eur J Biochem. 1974 Dec 16;50(1):305-15
pubmed: 4452361
Amino Acids. 2015 Apr;47(4):685-91
pubmed: 25676932
Br J Pharmacol. 2015 Oct;172(20):4996-5008
pubmed: 26228176
Bioessays. 2001 Dec;23(12):1112-9
pubmed: 11746230
Adipocyte. 2015 Jan 07;4(2):129-34
pubmed: 26167416
Cell. 2016 Mar 24;165(1):153-164
pubmed: 26972053
Age (Dordr). 2011 Sep;33(3):321-36
pubmed: 20878490
Eur J Biochem. 1993 May 1;213(3):1341-8
pubmed: 8504825
J Nutr. 2000 Nov;130(11):2630-5
pubmed: 11053498
Nat Cell Biol. 2005 Mar;7(3):286-94
pubmed: 15723049
Biochem J. 1995 Nov 15;312 ( Pt 1):163-7
pubmed: 7492307
J Cachexia Sarcopenia Muscle. 2017 Dec;8(6):1081-1083
pubmed: 29098794
Nat Protoc. 2008;3(6):965-76
pubmed: 18536644
Am J Physiol Endocrinol Metab. 2006 Sep;291(3):E582-6
pubmed: 16608884
J Nutr. 2015 Jul;145(7):1429-37
pubmed: 26019250
Mol Nutr Food Res. 2014 Dec;58(12):2320-30
pubmed: 25271764
J Biol Chem. 1998 May 15;273(20):12662-8
pubmed: 9575229
Br J Sports Med. 2002 Aug;36(4):282-9
pubmed: 12145119
Eur J Biochem. 2003 May;270(9):1887-99
pubmed: 12709047
J Cachexia Sarcopenia Muscle. 2019 Aug;10(4):919-928
pubmed: 31070021
FASEB J. 2011 Mar;25(3):1028-39
pubmed: 21148113
Cell. 2017 Apr 6;169(2):361-371
pubmed: 28388417
J Physiol. 2007 Jul 15;582(Pt 2):813-23
pubmed: 17478528
Amino Acids. 2012 Sep;43(3):1171-8
pubmed: 22160257
Clin Sci (Lond). 2017 Apr 25;131(8):775-790
pubmed: 28250083
Am J Physiol Endocrinol Metab. 2017 Jan 1;312(1):E27-E36
pubmed: 27827806
Mol Nutr Food Res. 2014 Sep;58(9):1765-75
pubmed: 24913603
J Proteome Res. 2005 Jul-Aug;4(4):1397-402
pubmed: 16083292

Auteurs

Arthur Goron (A)

Laboratory of Fundamental and Applied Bioenergetics, Univ. Grenoble Alpes and INSERM, Grenoble, France.

Frédéric Lamarche (F)

Laboratory of Fundamental and Applied Bioenergetics, Univ. Grenoble Alpes and INSERM, Grenoble, France.

Sandrine Blanchet (S)

Univ. Grenoble Alpes, Institute for Advanced Biosciences, INSERM, Grenoble, France.

Pascale Delangle (P)

Univ. Grenoble Alpes, CEA, CNRS, INAC-SyMMES, Grenoble, France.

Uwe Schlattner (U)

Laboratory of Fundamental and Applied Bioenergetics, Univ. Grenoble Alpes and INSERM, Grenoble, France.

Eric Fontaine (E)

Laboratory of Fundamental and Applied Bioenergetics, Univ. Grenoble Alpes and INSERM, Grenoble, France.

Christophe Moinard (C)

Laboratory of Fundamental and Applied Bioenergetics, Univ. Grenoble Alpes and INSERM, Grenoble, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH